Stride Stock Drops 12% Amid IVF Tech Funding News

(RTTNews) - Stride, Inc. (LRN) shares fell 12.38 percent to $138.75 on Monday, sliding $18.53, after Conceivable Life Sciences announced a $50 million Series A financing round to advance development of the world's first AI-powered automated IVF laboratory. The investment aims to scale and commercialize IVF technology for improved pregnancy outcomes. The stock opened at $158.00 and traded between $136.25 and $158.40, compared with a prior close of $158.36 on the New York Stock Exchange. Trading volume reached 1.3 million shares, well above the average of 637,459. Stride now trades within a 52-week range of $63.25 to $171.17.